A report in the Sydney Morning Herald says scientists in Australia are developing a miniature robot called the Neuroglide that would be able to navigate through the arteries of the human brain and remove life-threatening blood clots in stroke victims.
The report quotes neurointerventionist Bernard Yan as saying that currently about 15 percent of stroke victims die because the blood clot in their brain can’t be accessed down a winding path ...
continue reading...
Johnson & Johnson has set aside $3 billion to deal with the legal fallout from 93,000 all-metal hip implants recalled in 2010, according to a story in the Chicago Tribune. But the healthcare giant may face even more expenses down the line from more problems with a new line of hip implants.
The company’s DePuy Orthopaedics division is facing 3,000 lawsuits filed over the recalled model. And a subsequent model that ...
continue reading...
The Wall Street Journal reports that Johnson & Johnson and federal prosecutors have reached a settlement over allegations that the company illegally marketed its antipsychotic drug Risperdal and other medications.
That settlement will reportedly be about $2.2 billion, and include about $400 million in criminal fines.
But the settlement won’t be the end of Johnson & Johnson’s legal troubles. It’s still facing thousands of lawsuits from plaintiffs alleging that the company’sread more.... --> continue reading...
The New York Times reports that the U.S. Food and Drug Administration conducted a wide-ranging surveillance operation against its own scientists.
The agency used “spy software” designed to help employers monitor workers, and captured screen images from the government laptops of scientists as they were being used at work or at home.
Though federal agencies have broad discretion to monitor their employees’ computer use, the F.D.A. program may have crossed legal lines ...
continue reading...
Amid evidence that Johnson & Johnson continued to sell a dangerous vaginal mesh implant for nine months after the U.S. Food and Drug Administration ordered it to stop, some observers are questioning whether federal regulatory agencies are currently able protect consumers.
A Bloomberg story quotes University of Michigan business professor Erik Gordon as saying that the issue points out “the industry’s ability to shrug off FDA enforcement. If companies can get ...
continue reading...
Stryker Corp. of Kalamazoo, Mich., has announced a voluntary recall of components used in metal hip joints.
A report on CBS 62 in Detroit says Stryker’s Rejuvenate and ABG II modular-neck stems, despite their names, are used in hip implants.
Stryker said the recall was based on reports from the field of corrosion and “fretting,” which is corrosion made worse by abrasive wear. A Stryker news release says: “These risks include the ...
continue reading...
